Zenosense, Inc.: MIDS Shareholder Update

VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) — Zenosense, Inc. (OTC PINK: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care handheld device for the early detection of certain cardiac event biomarkers.  We believe that MIDS Cardiac will […]

QT Vascular Enters Into Asset Purchase And Option Agreement With Teleflex

SINGAPORE, May 24, 2018 /PRNewswire/ — QT Vascular Ltd., (“QT Vascular“, and with its subsidiaries, the “Company“), announced today that it has entered into an asset purchase and option agreement (the “APOA“) with Teleflex Life Sciences Unlimited Company and Teleflex Incorporated (“Teleflex“). Under the APOA, Teleflex will acquire the non-drug coated product line […]

Venus Medtech’s strategic investment in Keystone Heart deepens the technical layout of cerebral embolic protection market

HANGZHOU, China, May 23, 2018 /PRNewswire/ — China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation TriGUARD 3™ device and the next generation of cerebral embolic protection device in China and […]

Analytics 4 Life® Expands Its Medical Advisory Board with Global Experts in Cardiology

RESEARCH TRIANGLE PARK, N.C. & TORONTO–(BUSINESS WIRE)–Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced that it has expanded its Medical Advisory Board with the addition of two global experts in cardiology and digital health. Junbo […]

Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors

Malmö, May 23, 2018 Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors Acarix, developer of the CADScor®System for Coronary Artery Disease (CAD) risk assessment, today announced the appointment of a highly experienced marketing expert, Johanne Louise Brændgaard, as a member of the board of […]

MyoKardia Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 21, 2018 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that it has commenced a proposed underwritten public offering of 3,750,000 shares of its common stock. All shares of […]

Shenzhen Salubris Pharmaceuticals Announces Investment and In-Licensing Agreement With MedAlliance to Bring Novel Cardiovascular Disease Therapy to China

SHENZHEN, China–(BUSINESS WIRE)–Splendris International Limited, an affiliate of Shenzhen Salubris Pharmaceuticals Co Ltd. (Salubris), a multi-national leader in the development and commercialization of cardiovascular products in China and beyond, today announced a strategic investment and in-licensing agreement with Swiss cardiovascular pioneer M.A. MedAlliance S.A. (MedAlliance). Under the terms of the […]